2025
SJR Q2
JCR Q2 · 4,4
28 matched articles
SCIE
Journal detail
Biomedical Microdevices
- Publisher
- Springer
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
1387217615728781
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,66
- Quartile Q2
- H-Index 110
- Cites/doc 4,73
- Docs (3y) 126
- Cites (3y) 572
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 4,4
- 5Y JIF 3,5
- JCI 0,53
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Biomedical Engineering Q2
- Molecular Biology Q3
- Nanoscience and Nanotechnology Q2
Areas
- Biochemistry, Genetics and Molecular Biology
- Engineering
- Materials Science
WoS categories
- Engineering, Biomedical | Nanoscience & Nanotechnology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,66 | 4,4 | 3,5 | 0,53 | Q3 | 110 |
| 2024 | Q2 | Q2 | 0,551 | 3,3 | 3,3 | 0,47 | Q3 | 107 |
| 2023 | Q2 | Q3 | 0,578 | 3 | 3,4 | 0,53 | Q3 | 107 |
| 2022 | Q2 | Q3 | 0,526 | 2,8 | 3 | 0,52 | Q3 | 107 |
| 2021 | Q2 | Q3 | 0,573 | 3,8 | 3,2 | 0,57 | Q3 | 107 |
| 2020 | Q2 | Q3 | 0,629 | 2,8 | 2,8 | 0,58 | Q3 | 107 |
| 2019 | Q2 | Q3 | 0,611 | 2,2 | 2,3 | 0,57 | Q2 | 107 |
| 2018 | — | Q2 | — | 2,3 | 2,5 | 0,57 | Q2 | — |
| 2017 | Q2 | Q2 | 0,538 | 2,1 | 2,4 | 0,57 | Q2 | 107 |
| 2016 | Q2 | Q2 | 0,606 | 2,1 | 2,7 | — | — | 107 |
| 2015 | Q2 | Q2 | 0,768 | 2,2 | 2,4 | — | — | 107 |
| 2014 | Q1 | Q1 | 0,961 | 2,9 | 2,8 | — | — | 107 |
| 2013 | Q2 | Q2 | 0,882 | 2,8 | 3 | — | — | 107 |
| 2012 | Q1 | Q1 | 0,991 | 2,7 | 3,1 | — | — | 107 |
| 2011 | Q1 | Q1 | 1,151 | 3 | 3,4 | — | — | 107 |
| 2010 | Q1 | Q1 | 1,284 | 3,4 | 3,7 | — | — | 107 |
| 2009 | — | Q1 | — | 3,3 | 3,5 | — | — | — |
| 2008 | — | Q1 | — | 2,9 | 3,4 | — | — | — |
| 2007 | — | Q1 | — | 3,1 | 3,7 | — | — | — |
| 2006 | — | Q1 | — | 2,6 | — | — | — | — |
| 2005 | — | Q1 | — | 2,5 | — | — | — | — |
| 2004 | — | Q1 | — | 2,7 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q3 | 47/130 |
| 2025 | NANOSCIENCE & NANOTECHNOLOGY | SCIE | Q3 | Q3 | 77/148 |
| 2024 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q3 | 58/124 |
| 2024 | NANOSCIENCE & NANOTECHNOLOGY | SCIE | Q3 | Q3 | 85/147 |
| 2023 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 62/123 |
| 2023 | NANOSCIENCE & NANOTECHNOLOGY | SCIE | Q3 | Q3 | 84/141 |
| 2022 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 63/96 |
| 2022 | NANOSCIENCE & NANOTECHNOLOGY | SCIE | Q3 | Q3 | 75/108 |
| 2021 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 52/98 |
| 2021 | NANOSCIENCE & NANOTECHNOLOGY | SCIE | Q3 | Q3 | 68/109 |
| 2020 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 52/89 |
| 2020 | NANOSCIENCE & NANOTECHNOLOGY | SCIE | Q3 | Q3 | 77/106 |
| 2019 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 54/87 |
| 2019 | NANOSCIENCE & NANOTECHNOLOGY | SCIE | Q3 | Q2 | 73/103 |
| 2018 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q3 | 38/80 |
| 2018 | NANOSCIENCE & NANOTECHNOLOGY | SCIE | Q3 | Q2 | 56/94 |
| 2017 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q3 | 38/78 |
| 2017 | NANOSCIENCE & NANOTECHNOLOGY | SCIE | Q3 | Q2 | 61/92 |
| 2016 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 36/77 |
| 2016 | NANOSCIENCE & NANOTECHNOLOGY | SCIE | Q3 | — | 52/87 |
| 2015 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 28/76 |
| 2015 | NANOSCIENCE & NANOTECHNOLOGY | SCIE | Q2 | — | 41/83 |
| 2014 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 18/76 |
| 2014 | NANOSCIENCE & NANOTECHNOLOGY | SCIE | Q2 | — | 30/80 |
| 2013 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 20/76 |
| 2013 | NANOSCIENCE & NANOTECHNOLOGY | SCIE | Q2 | — | 28/73 |
| 2012 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 17/79 |
| 2012 | NANOSCIENCE & NANOTECHNOLOGY | SCIE | Q2 | — | 26/69 |
| 2011 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 13/72 |
| 2011 | NANOSCIENCE & NANOTECHNOLOGY | SCIE | Q2 | — | 27/66 |
| 2010 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 7/70 |
| 2010 | NANOSCIENCE & NANOTECHNOLOGY | SCIE | Q2 | — | 21/64 |
| 2009 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 7/59 |
| 2009 | NANOSCIENCE & NANOTECHNOLOGY | SCIE | Q2 | — | 16/59 |
| 2008 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 7/52 |
| 2008 | NANOSCIENCE & NANOTECHNOLOGY | SCIE | Q2 | — | 14/52 |
| 2007 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 5/44 |
| 2007 | NANOSCIENCE & NANOTECHNOLOGY | SCIE | Q1 | — | 8/47 |
| 2006 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 7/42 |
| 2006 | NANOSCIENCE & NANOTECHNOLOGY | SCIE | Q2 | — | 9/32 |
| 2005 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 7/41 |
| 2005 | NANOSCIENCE & NANOTECHNOLOGY | SCIE | Q1 | — | 6/27 |
| 2004 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 6/42 |